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Abstract.  The coat proteins required for budding 
COP-coated vesicles from Golgi membranes, coatomer 
and ADP-ribosylation factor (ARF) protein, are shown 
to be required to reconstitute the orderly process of 
transport between Golgi cisternae in which fusion of 
transport vesicles begins only after budding ends. 
When either coat protein is omitted, fusion is uncou- 
pled from budding-donor and acceptor compartments 
pair directly without an intervening vesicle. Coupling 
may therefore result from the sequestration of fuso- 
genic membrane proteins into assembling coated vesi- 
cles that are only exposed when the coat is removed 
after budding is complete. This mechanism of cou- 
pling explains the phenomenon of "retrograde transport" 
triggered by uncouplers such as the drug brefeldin A. 
H 
ow is membrane fusion coupled to vesicle budding? 
A transport vesicle must fuse with its target only 
after its budding from the parental membrane is 
completed. Otherwise, the various membrane-bound com- 
partments connected by vesicle shuttles would fuse and the 
topological organization of the endomembrane system in 
ceils would be destroyed. The basis for coupling can be more 
precisely formul~ited. As each transport vesicle presumably 
carries with it certain membrane proteins derived from the 
parental membrane that will later be needed to attach to 
receptors at the target membrane to initiate fusion, there 
must be a coupling mechanism to prevent these same "fu- 
sion" proteins from initiating premature (e.g., uncoupled) 
fusion while they still reside in the parental compartment. 
One mechanism to ensure coupling would be to activate 
membrane fusion components as they enter transport vesi- 
cles, or at some later stage of vesicle maturation. A simpler 
mechanism is afforded to transport vesicles that bud with a 
cytoplasmic protein coat, such as the clathrin coat for en- 
docytosis (Pearse and Robinson, 1990) or the COP coat for 
ER and Golgi transport (Rothman and Orci, 1992). The per- 
tinent membrane fusion proteins of the parental membrane 
could simply be sequestered in the coats of budding vesicles 
until the coat is removed after completion of  budding. A pro- 
cess that efficiently packages fusion proteins in assembling 
vesicles must be a part of any budding mechanism, and is 
easy to envision for coated vesicles. 
COP-coated vesicles form from Golgi stacks incubated 
with cytosol and a source of  energy, ATP (Balch et al., 1984; 
Address  all correspondence to J.  E.  Rothman, Program in Cellular Bio- 
chemistry and Biophysics, Memorial Sloan Kettering Cancer Center,  1275 
York Avenue, New York, NY 10021. 
Orci et al., 1989). Purification of COP-coated vesicles (Mal- 
hotra et al., 1989; Serafini et al., 1991a,b) revealed that their 
coats consist of  a small GTP-binding protein (ADP-ribosyla- 
tion factor, ARF)  ~  and a complex of seven distinct proteins 
termed coatomer (Waters  et al.,  1992a;  Stenbeck et al., 
1993),  whose subunits are or, B, B', 3', ~, e, and ~'-COPs. 
Coatomer and ARF exist separately in cytosol, but coassem- 
ble to form coats. Assembly is initiated when the GTP form 
of ARF (which must be N-myristylated) binds to a mem- 
brane  receptor  following a  brefeldin A-  (BFA)  sensitive 
nucleotide exchange step (Donaldson et al.,  1992b;  Helms 
and Rothman, 1992; Helms et al.,  1993).  This membrane- 
bound form of ARF affords a binding site for coatomers, 
(Donaldson et al., 1992a;  Palmer et al., 1993) and budding 
occurs  as  the  coatomers  bind  (Orci  et  al.,  1993a,b). 
Coatomer and ARF are the only cytosolic proteins that ap- 
pear to be necessary for budding (Orci et al.,  1993a).  The 
coat disassembles when ARF is triggered to hydrolyze  bound 
GTP (Tanigawa et al., 1993), most likely at the target mem- 
brane. 
A body of strong correlative evidence (reviewed in Roth- 
man and Orci,  1992) from cell-free transport reactions led 
to the view (Orci  et al.,  1989)  that COP-coated vesicles 
mediate protein transport from ER to Golgi and between 
successive cisternae of the Golgi stack. This conclusion has 
recently been confirmed in living cells by both biochemical 
and  genetic  methods.  Microinjection  of an  antibody  to 
B-COP blocked transport of the VSV-G protein up to but not 
beyond the  trans-Golgi (Pepperkok  et  al.,  1993),  and  a 
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logue of v-COP (Stenbeck et al.,  1992)  and also to be a 
subunit of a complex isolated from yeast cytosol that con- 
tains subunits of similar size to animal coatomer (Hosobuchi 
et al.,  1992).  When the two genes encoding ARF in yeast 
are deleted,  secretion stops and cells die (Stearns et al., 
1990a,b). 
The  cell-free Golgi transport  assay that defined COP- 
coated vesicles and delineated their role in transport involves 
the coincubation of two types of Golgi fractions in the pres- 
ence of ATP and cytosol-derived fractions (Fries and Roth- 
man,  1980;  Balch et al.,  1984).  The donor population of 
Golgi membranes is obtained from VSV-infeeted CHO mu- 
tant (clone 15B) cells unable to add the sugar N-Aeetylglu- 
cosamine  (GlcNAc)  to  glycoproteins due  to  an  enzyme 
deficiency, and the acceptor population of Golgi membranes 
is from uninfected wild-type CHO cells. A signal in the assay 
results when G protein from donor membranes is glycosyl- 
ated by the GlcNAc-transferase from acceptor membranes 
recorded by transfer of pI'I]GIcNAc from UDP-[3I-I]GlcNAc 
to VSV-G protein. In crude cytosol, the assay signal is prin- 
cipally due to COP-coated vesicles that carry VSV-G protein 
from cis-Golgi cisternae in the donor stacks to the medial- 
Golgi cisternae in the acceptor stacks that house GIcNAc 
Transferase I (Rothman et al., 1984; Orci et al,, 1989; Roth- 
man and Orci, 1992). However, in principle, or under differ- 
ent conditions, a  direct (uncoupled) fusion among Golgi 
stacks would also result in an assay signal (Mellman and Si- 
mons,  1992). 
Given the recently defined and clearly delineated roles of 
ARF and coatomer in COP-coated vesicle budding, and the 
confirmation of the requirement for these proteins in vivo, 
these proteins are expected to be required for vesicular trans- 
port of VSV-G protein in the cell-free system. We now report 
a surprising finding obtained as a result of systematic frac- 
tionation ofcytosol (Block et al., 1988; Clary and Rothman, 
1990; Waters et al., 1992b) to yield the minimum set of  com- 
ponents needed for efficient  reconstitution of an assay signal: 
coatomer and ARF are not among these components. In in- 
vestigating this apparent  discrepancy,  we  discovered that 
with these minimal components the assay signal now results 
from uncoupled, direct fusion of Golgi stacks that occurs 
when either ARF or coatomer is absent. Adding back both 
coatomer and N-myristylated ARF protein restores  cou- 
pling.  Now coated vesicles assemble, but cannot be con- 
sumed due to the lack of a releasing factor. When this releas- 
ing factor is also added back, the assay signal is restored, 
now due to vesicular transport as fusion is once again cou- 
pled to budding, as in crude cytosol. These findings offer 
clear confirmation of the role of ARF and coatomer in cell- 
free transport, and also define a novel role for the coat pro- 
teins, coupling of fusion to budding. This new role allows 
a straightforward explanation of the phenomenology associ- 
ated with brefeldin A  (BFA)  in its effects on "retrograde 
transport" from Golgi to ER (Klausner et al.,  1992). 
Materials and Methods 
Materials 
BFA, obtained from  Epicenter Technologies Corp. (Madison, Wl) was dis- 
solved in methanol. ATP, UTP,  palmitoyl-Coenzyme  A, and DTT were 
from  Boehringer  Mannheim Corp.  (Indianapolis,  IN).  Creafin  phos- 
phokinase, creatine phosphate, and nucleotide monophosphate kinase were 
obtained from Sigma Chemical Co. (St. Louis, MO). Affinity-purified an- 
tiserum to e-COP was a gift of Dr.  S. Knge, and a monoclonal antibody 
against E-COP  (M3A5) was kindly donated by Dr.  1". E. Kries.  Affinity 
purified antibodies a  cain~t ARF were prepared as described (Palmer et al., 
1993). Donor and acceptor membrane fractions were prepared from VSV- 
infected CHO 15B and wild type CHO cells, respectively, as described pre- 
viously (Balch et al., 1984). Salt extracted Golgl membranes were prepared 
as described (Waters et al.,  1992/7). Bovine brain ¢ytosol was prepared by 
the method of Malhotra et al. (1989). 
Cis- to Medial-Transport  Assay 
The assay is a modification  of that previously  described by Waters et al. 
(1992/7). 2.5 ~tg CHO 15B Golgi membranes (lacking N-acetylglucosemine 
transferase)  infected with VSV (donor) were mixed with 2.5 ~g wild-type 
CHO Golgi (acceptors)  and incubated for 1 h at 37°C in the presence of 
25 mM Hepos-KOH,  pH 7.2, 40 mM KCI, 2.5 mM Mg(OAc)2, 100/tM 
ATP, 250 ~M UTP, 5 mM creatine phosphate, 8 IU/ml creatine phosphate 
kinase,  10 ttM palmitoyl-Ccenzyme A, 40 ~g/ml nucleotide  monophos- 
pbate kinase,  200 mM sucrose,  0.6/~Ci UDP-[3H]-N-acetylglucosamine 
([3H]GIcNAc). The reaction mixtures were supplemented with either 10 
ng His~-NSF (Whiteheart et al., 1993), 60 ng Hise-,~-SNAP (Soluble NSF 
attachment protein) (Whitebeart et al.,  1993), 0.5/~g p115 (Waters et al., 
1992b), 60 ~g fraction Ia and 60 ~g fraction I0 or with 80 ~g bovine brain 
cytosol, in a total volume of 50/~1. [3H]GIcNAc incorporated into VSV-G 
protein was detected by immunoprecipitation of VSV-G protein and scintil- 
lation counting (Balch et al.,  1984). 
Purification of  Different Cytosolic Factors 
Fractions Ic~ and I~ were obtained by chromatography of 100 ml bovine 
brain cytosol (10 mg/ml) on a 20 ml Mono Q column equilibrated with 25 
mM Tris-HC1, pH 7.4, 50 mM KC1, 1 mM DTT, and 10% glycerol (Waters 
et al., 1992b). The column was washed with 40 ml of the same buffer and 
then eluted with 50-500 mM KC1 gradient in 160 mi. 3-ml fractions were 
collected, dialyzed to reduce the KCI concentration to 50 mM, and assayed 
for transport activity in the presence of 0.5/tg pl15,  10 ng His6-NSF, 60 
ng Hiss-a-SNAP and 5/~g 1 M KCl-extraeted Golgl membranes. Activities 
corresponding to I~ were ehited at 210 mM KCI and to I~ at 280 mM KCI. 
During the course of this study we have also used a mixture of Ic~ and I~ 
(termed Ia+ ~) which corresponds to a pool of the fractions ehited from the 
Mono Q column between 200 mM and 290 mM KC1. 
Recombinunts His6-NSF and Hi&s-a-SNAP were prepared as described 
(Whiteheart et al.,  1993). Recombinunts mARFI and ARFI were purified 
as described (Weiss et al.,  1989) and pl15 was purified  from bovine liver 
cytosol as described (Waters et al.,  1992b). 
Western Blot Analysis 
Proteins were fractionated on SDS-PAGE and electroblotted  on to nitrocel- 
lniose in 25 mM Tris,  192 mM glycine, and 20% methanol at 22V/cm for 
I h. ARF and e-COP were detected using affinity pudfied IgG (1:2,000) and 
peroxidase conjugated anti-rabbit  IgG (diluted 1:2,000). ~42OP vats detected 
using the mouse monoclonal M3A5 (0.4 ~tg/mi, (Allan and Kreis,  1986)). 
Peroxidaso labeling was detected by chemiluminescence using the ECL re- 
agent (Amersham Corp., Arlington Heights, IL). ~OP  signals were quan- 
titated by imaging with a Scan Jet Plus scanner (Hewlett Packard,  CA) and 
integration of images using the ScanAnalysis  software from Biosofl (Cam- 
bridge, United Kingdom).  ~-COP and ARF were immunodetected on the 
top and the bottom halves of nitrocellulose  blots, respectively. 
Results 
Fusion Uncoupled  from Budding 
We have previously reported that an assay signal is recon- 
stituted to (LM KC1) salt-washed Golgi membranes by NSF 
and  SNAPs  in  combination with  three  distinct cytosol- 
derived factors, termed Iot, I~, and IT, and that purification 
of Factor I'y reveals it to be a  trimer of ll5-kD subunits 
(13115) (waters et al.,  1992b).  This mixture of components 
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cytosol to both KCl-washed and untreated Golgi membranes 
(Fig. 1 a). The requirements for each component or fraction 
are  less  complete with untreated than KCl-washed mem- 
branes presumably because the membranes contribute an ad- 
sorbed pool of each component that is removed by the salt 
wash. When the amounts of fractions Ia, 1/3, and pl15, and 
of Golgi membranes (not salt washed) that are used in stan- 
dard assays (Fig. 1 a) were analyzed by Western blotting, no 
coatomer or ARF were detected (Fig.  1 b).  The NSF and 
a-SNAP proteins used were recombinant from E.  coli and 
could not provide ARF or coatomer.  Standard (not KCI- 
washed) Golgi membranes are used throughout this study, al- 
though similar results are obtained with KCl-washed mem- 
branes. 
Because coatomer and ARF are both required for coated 
vesicles to bud from Golgi membranes (Orci et al., 1993a), 
Figure L (a) Cytosolic factors required for reconstitution  of  the cell 
free assay. CHO 15B Golgi membranes were mixed with wild-type 
CHO Golgi and incubated for  1 h at 37°C in the presence of 
[3H]GIcNAc, 10 rig His~-NSF, 60 ng His~-c~-SNAP 0.5 #g pl15, 
60 #g fraction hx, and 60 #g fraction IB as indicated. Shown are 
results using standard CHO-Golgi membranes (m) or 1M KCI ex- 
tracted CHO-Golgi (~).  (b) Western blotting analysis of the dif- 
ferent cytosolic fractions. 48 #g bovine brain cytosol (lane 1), 5 
#g CHO Golgi (lane 2), 60/zg fraction Ia (lane 3), 60/zg fraction 
143 (lane 4), 0.5 #g p115 (lane 5), 0.5 tzg recombinant  mARF (Weiss 
et al.,  1989; Duronio et al.,  1990) (lane 6),  and  1 /zg purified 
coatomer (Waters  et al., 1992a) (lane 7) were fractionated on SDS- 
PAGE using 10%  gel under reducing conditions. Coatomer and 
ARF were detected by Western blotting as described in Materials 
and Methods. 
and because coated vesicles (and derived uncoated vesicles) 
are the only products of budding observed in the cell-free 
system (Orci et al.,  1993b),  the simplest interpretation of 
this surprising result is that the assay signal in the presence 
of this coat protein-deficient mixture of cytosol components 
(NSE SNAP, pl15, Ia, 1/3; hereafter termed "presumed fu- 
sion components") is due to a direct fusion between the do- 
nor and acceptor Golgi membranes, not involving transport 
vesicles. 
When coatomer and myristylated ARF1 (mARF1) protein 
are added back with the presumed fusion components, the 
assay signal is inhibited at least 70% (Fig. 2 a, e). Inhibition 
of the presumed direct fusion reaction requires both coat- 
omer and mARF1  (Fig. 2 a,  o) and ARF must be myris- 
tylated (Fig. 2 a, o). These conditions inhibiting presumed 
direct fusion are precisely those that allow coated vesicles to 
form (Orci et al.,  1993b),  and indeed coated vesicles and 
coated buds accumulate (Fig. 2 c) under the same conditions 
in which the presumed direct fusion reaction is blocked. 
When Golgi are incubated with presumed fusion compo- 
nents and mARF1 in the absence of coatomer, conditions in 
which presumed direct fusion can proceed (Fig. 2 a), elec- 
tron microscopy (Orci et al., 1993a,b) reveals that there are 
(per t~m  2 of Golgi area) 2.8  +  0.6 uncoated vesicles, 3.0 + 
0.9 coated vesicles, and 3.0  +  0.7 coated buds.  However, 
when coatomer (2 t~g) is also added, inhibiting presumed di- 
rect fusion to 30% of the maximal value (Fig. 2 a), now there 
are 2.0 -t- 0.4 uncoated vesicles, 10.1 :t: 1.0 coated vesicles, 
and 11.4 5:1,8 coated buds O0 Golgi areas examined in each 
case). The limited production of coated vesicles in the ab- 
sence of  added coatomer may reflect trace levels endogenous 
to the fractions used. 
Consistent with a causal connection between the assembly 
of coated buds and coated vesicles and the inhibition of the 
presumed direct fusion, adding GTPTS, which further ac- 
cumulates coated vesicles (Melan~on et al., 1987),  potenti- 
ates the coatomer and mARFl-dependent inhibition of pre- 
sumed direct fusion (Fig.  2  a,  .).  Furthermore,  BFA,  a 
drug that blocks the assembly of coated vesicles (Orci et al., 
1991) by inhibiting GTP-GDP exchange (Donaldson et al., 
1992b;  Helms and Rothman, 1992),  thereby preventing the 
binding of  ARF and coatomer to Golgi membranes (Donald- 
son et al., 1992a;  Palmer et al.,  1993),  prevents the inhibi- 
tion of the presumed direct fusion reaction by coatomer and 
mARF1 (Fig. 2 a, A). 
Whereas coatomer and mARF1  inhibit the assay signal 
produced by the presumed fusion components, the coat pro- 
teins have no inhibitory effect upon the signal produced by 
crude cytosol (Fig. 2 b). This implies that crude cytosol pro- 
vides an additional factor (which we term RF, for "releasing 
factor") that is not needed for the presumed direct fusion 
reaction (and was thus removed during the fractionation to 
yield the minimum set of components needed for an assay 
signal), but which is needed for the assay to operate in the 
presence of coatomer and mARFI. The postulated releasing 
factor has been identified in fractions of  crude cytosol on the 
basis of its ability to allow an assay signal in the presence 
of the presumed fusion components, coatomer, and mARF1. 
Fractionation on a Superose 6 column leads to clear resolu- 
tion and partial purification of RF activity (Fig. 3 a) eluting 
at approximately 14,000  native molecular weight. This RF 
fraction does not contain coatomer, NSF, pl15, ARE or-SNAP, 
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Figure  2.  (a)  Coatomer  and 
mARF inhibit the assay signal 
reconstituted  with  presumed 
fusion  components.  Purified 
coatomer was titrated into 50 
#1 reactions containing 2.5 #g 
each  donor  and  acceptor 
Golgi,  and  presumed  fusion 
components (10 ng His6-NSE 
60  ng  His6-cx-SNAP, 0.5  #g 
p115,  and  60  /~g  fraction  I 
oe+~) (c~). 0.5  ~g ARF1 (o), 
0.5  #g  mARF1  (e),  0.5  #g 
mARFI plus  10  #M  GTP3,S 
(g), 0.5  /~g mARF1 plus 150 
#M  brefeldin  A  (zx) were 
added in addition to the pre- 
sumed fusion components. In- 
corporation  of  [3H]GIcNAc 
into VSV-G protein was deter- 
mined after 1 h of incubation 
at 37°C.  100% corresponds to 
1950 cpm (o), 2350 cpm (o), 
2250 cpm (e), 1,820 cpm (zx), 
and  2085  cpm  (m).  (b) 
Coatomer and mARF do not 
inhibit transport reconstituted 
with  crude  bovine  brain 
cytosol.  Golgi  membranes 
were  either  incubated  with 
presumed fusion components 
(as in a) plus 0.5 #g mARF1 
(B)  or  with  80  #g  bovine 
brain  cytosol  plus  0.5  #g 
mARF1 (o) and the indicated 
amount  of  coatomer.  100% 
corresponds to 2,650 cpm (-) 
and 4,230 cpm (o). (c) Elec- 
tron microscopy of Golgi frac- 
tions.  100  #1  Golgi  mem- 
branes  were  incubated  (in 
final volume of 1 ml) with pre- 
sumed fusion components (as 
in a) and 5 #g mARF in the 
presence  (1)  or  the  absence 
(2) of 20 #g coatomer for 20 
min at 37°C. The membranes 
were  then  pellet,  fixed  and 
processed as described (Orci 
et al.,  1986, 1991). (1)  Pre- 
sumed  fusion  components, 
rnARF  and  coatomer.  Note 
the accumulation of non clath- 
rin-coated buds  and  vesicles 
(arrows).  (2)  Same as  1  but 
coatomer was  omitted.  Note 
the  predominance  of  flat 
cisternal  elements  (arrow- 
heads). Bars: (C, 1) 0.24 #m; 
(C, 2) 0.26 #m. 
The Journal of Cell Biology,  Volume 124, 1994  418 t-SNAP,  or v-SNAP,  as judged  by Western  blotting,  nor 
does it yield a signal when assayed alone with Golgi mem- 
branes  at  concentrations  that  can  reverse  coatomer  and 
mARF inhibition (data not shown). Moreover, while adding 
RF to presumed direct fusion reactions that are blocked by 
coatomer and  mARF1  restores  the  assay  signal,  RF  has 
no effect on transport assays conducted with crude cytosol 
(Fig.  3 b). 
Given that assembly of coatomer with mARF1 into coats 
on Golgi membranes blocks the presumed direct fusion reac- 
tion, RF could in principle allow an assay signal either by 
preventing coat assembly in the first place, or by allowing al- 
ready  assembled  coated vesicles  to  be  productively  con- 
sumed (in the simplest view by helping to remove the coat 
after assembly/budding). We can eliminate the first possibil- 
ity  because  RF  does  not  prevent coat  assembly:  mARF- 
dependent coatomer binding to Golgi membranes (a direct 
measure of coated vesicle assembly) (Orci et al.,  1993a,b; 
Palmer et al.,  1993)  is not affected by RF under the same 
conditions in which RF restores the assay signal (Fig. 3 c). 
That RF acts after coat assembly is confirmed by the finding 
that two conditions that prevent uncoating of coated vesicles 
(use of GTP'yS [Melan~on et al., 1987] or a mutant of ARF- 
Q71L [Tanigawa et al.,  1993]  that binds but does not hydro- 
lyze GTP) permit coatomer and mARFl-dependent inhibi- 
tion of the presumed fusion reaction, but do not allow RF 
to relieve this inhibition (Fig.  3 d). 
To summarize, the simplest interpretation is that in the ab- 
sence  of coatomer and  ARF,  Golgi  membranes can  fuse 
directly with each other in a reaction uncoupled from vesicle 
budding that nonetheless uses the same set of cytosolic fu- 
sion components (NSF, SNAP, pl15, Ion, IB) as do transport 
vesicles. When coatomer and ARF are added back, this di- 
rect fusion  reaction is blocked by a  mechanism requiring 
coat assembly. However, despite the presence of fusion com- 
ponents,  the  accumulated  transport  vesicles  (containing 
VSV-G protein)  cannot fuse with the GlcNAc transferase- 
containing acceptor Golgi due to the lack of a final cytosolic 
factor (RF) which is not needed for membrane fusion per se, 
but is needed to make the vesicles encased in coats available. 
Thus, adding back RF restores the assay signal as accumu- 
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Figure 3. (a) Chromatography 
of  bovine brain cytosol on Su- 
perose  6.  0.3  ml  of bovine 
brain cytosol (16 mg/ml) were 
loaded on a 24 ml Superose 6 
(HQ  10/30, Pharmacia  Fine 
Chemicals,  Piscataway,  NJ) 
column  equilibrated  with  25 
mM  Tris-HCl,  pH  7.4, 150 
mM  KC1,  1 mM  DTT, and 
10%  glycerol.  0.5-ml  frac- 
tions were collected and 10 ~1 
samples were added to trans- 
port  assays  (as  described  in 
Fig. 2) in the presence or the 
absence of 1 /~g coatomer.  A 
unit of RF activity is defined 
as the  ratio  of cpm incorpo- 
rated  in  the  presence  of 
coatomer to that incorporated 
in its absence (e). Arrows in- 
dicate  the  elution  position 
(OD2s0) of molecular  weight 
markers of 669, 158, and 13.7 
kD.  (b)  Cytosolic  releasing 
factor (RF) reverses the inhi- 
bition  by  coatomer  and 
mARF1.  Fractions  36-38 
eluted  from the  Superose  6 
column  were  pooled  and 
titrated  into  50-#1 transport 
reactions (as described in Fig. 
2) in the presence of 80 tzg bo- 
vine brain  cytosol  (o),  pre- 
sumed fusion factors and 0.5 gg mARF1 (t2), or the same plus 1/~g coatomer (e). (c) Lack of effect of RF on mARF dependent coatomer 
binding.  Golgi membranes were incubated with presumed  fusion components  (Fig.  2) and with 2 gg coatomer for 10 min at 37°C. 
Myristylated  ARF1 (0.5 gg) (lane 3-6), RF (1 gg) (lanes 5 and 6) and 20 gM GTP3,S (lines 2, 4, and 6) were included in the binding 
reaction when indicated. Golgi membranes were then pelleted through a 15 % (wt/wt) sucrose cushion, proteins were fractionated on 10% 
SDS-PAGE under reducing conditions, and coatomer was detected by Western blotting using the M3A5 antibody (directed against B-COP). 
(d) RF does not prevent coat assembly. RF was assayed (50 ~1 final volume) in the presence of: mARF1 (0.5 gg) (lanes 1-3), mARF1-Q71L 
(0.5 gg) (Gin was changed to Leu at codon 71 in human recombinant  ARF1 by site directed mutagenesis  to reduce GTP hydrolysis) 
(Tanigawa et al., 1993) (lanes 4-6) or mARF1 and 20 gM GTPyS (lanes 7-9). Transport activity was measured without coatomer (lanes 
1, 4, and  7), with coatomer (2 gg) (lanes 2, 5, and 8), or in the presence of coatomer and RF (1 gg) (lanes 3, 6, and 9). 
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signal 0ike that with crude cytosol) is due to transport by 
coated vesicles, rather than to direct (uncoupled) fusion of 
Golgi membranes (as in the absence of the coat proteins). 
Distinguishing Vesicular Transport from 
Uncoupled Fusion 
This interpretation has been confirmed by two direct and in- 
dependent tests. In the first method, which is empirical, we 
take advantage of the fact that the only mechanism by which 
GTP3,S can block the cell-free assay is by trapping mARF 
in its GTP-bound form, preventing uncoating of coated vesi- 
cles (Tanigawa et al.,  1993). Therefore, inhibition of the as- 
say signal by GTP-yS is the sine qua non of a reaction using 
coated vesicles. The assay signal produced by Golgi mem- 
branes in the presence of crude cytosol is profoundly in- 
hibited by GTP-yS (Fig. 4,  -), while that produced by the 
presumed  fusion components is  not inhibited  by GTP-yS 
(Fig. 4, e). The signal restored by RF when uncoupled fu- 
sion is prevented by coatomer and mARF1 (Fig. 4, o) is as 
inhibited by GTPTS as is the signal produced by crude cyto- 
sol, diagnostic of the use of coated transport vesicles. As 
would be predicted, further adding BFA to prevent coated 
vesicles from assembling makes the signal resulting from fu- 
sion  components,  mARE  coatomer, and  RF  resistant  to 
GTPTS (m);  now,  even though coat proteins are present, 
they cannot assemble into coats. 
The second test is based on first principles (Fig. 5), using 
a  competition experiment that  distinguishes  direct fusion 
from vesicular transport. For this purpose, we added a third 
Golgi population (from uninfected CHO clone 15B cells) to 
otherwise standard  transport reactions.  These  15B  Golgi 
contribute neither VSV-G protein (being from uninfected 
cells) nor GIcNAc Transferase I (being from mutant cells), 
but can act as a "silent acceptor" of transport vesicles. Thus, 
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Figure 4. GTP~,S  inhibition of Golgi protein transport. Increasing 
concentrations of  GTP},S  were added to assays (50 td) reconstituted 
with 80/~g bovine brain cytosol (I), presumed fusion components 
(e),  presumed  fusion  components plus  0.5  /~g mARF1, 2  /~g 
coatomer and 5 t~g RF (o) or the same plus 150 pM brefeldin A 
03). 100% corresponds to 4,507 cpm (I), 2,251 cpm (e), 1,851 
cpm (o), and 3,016 cpm 03). 
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Figure 5. Competition of the in vitro assay signal by uninfected 
CHO  15B Golgi.  (a) The assay signal resulting from vesicular 
transport is competed I  V uninfected CHO 15B Oolgi. A diffusible 
intermediate (vesicle) that is involved in the transport of VSV-G 
protein in vitro will have a similar probability to dock to CHO wild- 
type  and  15B Golgi.  Thus,  increasing concentrations of Golgi 
membranes derived from CHO mutant 15B will result in a decrease 
in VSV-G protein that is processed by the N-acetylglucosamine 
transferase in wild type Golgi. To calculate the predicted inhibition 
curve we have used the following equation: 
s 
$5o  WT +  15B 
where S = predicted assay signal, $50 =  signal measured with 1:1 
protein weight ratio of donor and acceptor Golgi; 15B =  amount 
(#g protein) of  total 15B CHO Golgi present (donor and uninfected 
15B Golgi); and WT =  amount (#g protein) of wild-type CHO 
Golgi. (b) An assay signal resulting from direct fusion of Golgi 
cisternae is not competed by uninfected CHO 15B Golgi. Direct fu- 
sion  between  the  Golgi  cistemae  could  in  principle  result  in 
glycosylation of VSV-G protein, but this signal would not be in- 
hibited by uninfected 15B. Increasing concentrations of uninfected 
15B would only dilute the concentrations of VSV-G protein and 
N-acetylglucosamine transferase in mixed fused Golgi membranes 
but would not affect the extent of glycosylation of G protein (e.g., 
S/SIn =  1). These models assume that there is a single round of 
vesicular transport in the cell free system, an assumption for which 
there is considerable evidence (for example see Rothman et el., 
1984; and Orci et al.,  1988). 
if a  vesicle transport mechanism applies (Fig.  5 a),  each 
VSV-G-containing vesicle emanating  from a  donor stack 
will have to choose, on a random basis, either the 15B com- 
petitor Golgi or the wild-type acceptor Golgi, but not both. 
Fusion with the wild-type Golgi will result in glycosylation 
and thus an assay signal; fusion with the 15B Golgi will not. 
As the proportion of 15B Golgi increases, the assay signal 
will monotonically decrease in a predictable fashion (as can 
be calculated from the relative amounts of donor, acceptor, 
and competitor Golgi present;  the donor VSV-15B Golgi 
must be taken into account as they also lack GlcNAc Trans- 
ferase I and therefore contribute to the silent aceeptor popu- 
lation. See legend to Fig. 5 for details of calculation). How- 
ever,  should  the  donor and  acceptor Golgi  fuse directly 
together to generate the assay signal (Fig. 5 b), then the 15B 
Golgi will not compete, because the G  protein (from the 
VSV-15B Golgi) and GIcNAc Transferase (from wild type 
CHO Golgi) will meet irrespective of whether 15B Golgi 
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sugar transferase nor G  protein.  Of course, as additional  ~  _~ 
neutral (15B) Golgi membrane is added, the rate of glycosy-  ~ 
lation may eventually slow, but in practice this effect has not 
been observed in the range of 15B membrane concentrations 
we have used, the extent of inhibition of the assay signal by 
15B membranes is independent of the time of incubation be- 
yond 1.5 h (not shown). 
To provide confirmation of the validity of the method, we 
apply it to the assay signal  resulting from crude cytosol, 
which much earlier evidence implies is due to coated trans- 
port vesicles (Orci et al.,  1989; Rothman and Orci,  1992), 
and to a situation in which Golgi stacks are already known 
to fuse, e.g., in the presence ofBFA (Orci et al.,  1991). (In 
addition to preventing coated vesicles from assembling, add- 
ing BFA to call-free incubations of Golgi membranes and 
crude cytosol results in extensive fusion of cisternae within 
a stack and between stacks [Orci etal.,  1991].) When 15B  b 
Golgi arc added to incubations of Golgi with crude cytosol,  ~  _ 
the assay signal is progressively reduced (Fig. 6 a, .), in rea-  i~ 
sortable agreement with the line predicted for random choice 
competition for transport vesicles (dashed line in Fig. 6 a).  ~  "~ 
However, when BFA is added under conditions known to re-  ~ 
suit in extensive fusion, little competition resulted (o); a re-  -= -  =u 
sidual competition could be due to incomplete blockade of  ,~ -~ 
coat assembly by BFA (Orci et al.,  1991). We also used an  ~ 
engineered mutant of ARF (expressed and N-myristylated in  ~' 
E. coil) in which residue 31 is changed from Thr to Ash, pre- 
pared in analogy to a dominant Ras mutant (S17N) that inter-  "~ 
feres with nucleotide exchange of  wild-type Ras (Fransworth  ~  > 
and Feig, 1991) to mimic the effect of BFA. Adding mARF1- 
T31N is equivalent to adding BFA in the competition assay 
(Fig. 6 a, m), and like BFA results in an assay signal that is 
resistant to GTP3,S (data not shown). 
The signal presumed to be due to direct fusion when Golgi 
membranes are incubated with NSF, SNAP, I~, and I/3 in the 
absence of coatomer and ARF  can now be confirmed as 
such, as 15B Golgi do not reduce this signal (Fig 6 b,  o). 
As  expected,  this  direct fusion persists  when mARF1  is 
added without coatomer (Fig. 6, o), but when coatomer and 
mARFI are added together with RF, as expected the restored 
signal is due to vesicular transport (Fig. 6 b, o), as was the 
case with crude cytosol (Fig. 6 a, e). Examination by elec- 
tron microscopy (not shown) of membrane pellets from reac- 
tions exhibiting direct fusion does not reveal evidence for the 
kind of extensive membrane fusion observed with BFA (Orci 
et al., 1991), in which numerous Golgi stacks and cisternae 
became fused into a  single network. Fusion of individual 
stacks of cisternae would be difficult to detect by this crude 
method. 
Discussion 
The expected requirement of cell-free vesicular transport for 
coatomer and ARF proved difficult to elucidate in a straight- 
forward manner, because of the dual role these coat compo- 
nents play in driving vesicle budding and also in coupling fu- 
sion to budding. When either coatomer or ARF is removed, 
or when present but prevented from assembling onto mem- 
branes (e.g., when BFA is added), a process of uncoupled 
fusion is unleashed that creates an assay signal that mimics 
the vesicular transport signal in quantity but not in its under- 
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Figure 6. (a) Brefeldin A and mARF1-T31N induce direct fusion  be- 
tween Golgi cisternae. The ratio of 15B Golgi (from donor plus 
uninfected 15B)  to wild-type Golgi plus 15B derived Golgi was var- 
ied from 50 to 83 % by diluting an assay reaction that had a standard 
1:1 (wt/wt) mixture of  donor and aceeptor membranes with increas- 
ing amounts of a correspondingly prepared  reaction containing 
only uninfected 15B Golgi (100/~g/ml). All reactions contained 1.6 
rag/ml bovine brain cytosol with no addition (o), or with 150/~M 
brefeldin A (o) or with 72/~g/mi mARF1-T31N (n). (The ARF1 
mutant was constructed by site-dire•ted mutagenesis [Thr to Ash 
at codon 31], expressed in the pET1  ld vector, and produced in E. 
coil that coexpressed N-myristoyltransferase.) Reactions were in- 
cubated for 90 rain at 37"C, and [3I-I-JGIcNAc  incorporated into 
VSV-G protein was determined (S) and expressed as fraction of  the 
value  (100%) observed .with the  standard  reaction  (Sso). The 
results for the standard assay (1:1 VSV-15B donor to wt aceeptor), 
or Ss0 to which all other data normalized are: 4239 cpm (bovine 
brain  cytosol),  3240  cpm  (eytosol plus  BFA) and  5,200  epm 
(cytosol plus rnARF1-T31N). The dashed lines represent the pre- 
dicted results for vesicles transport and direct fusion. (b) Coatomer 
and mARF1 couple fusion to vesicle budding. A competition ex- 
perimem was performed as described above. Assays (performed as 
in a) contain presumed fusion components (n), the same plus 10 
/~g/ml mARF1 (o), or plus 10/~g/ml mARF1, 40 #g/ml coatomer, 
and 50 tLg/ml  RF (o). S~ are 2,252 cpm (n), 2,650 cpm (o), and 
3,888 cpm (o). 
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only when certain components (ARF and coatomer) that are 
normally present in cells are removed, (or when a drug, BFA 
is added), this event is properly regarded as an uncoupled 
partial reaction of the transport pathway. 
It is often the case in biochemistry that removing a compo- 
nent from a  closely coupled system results in uncoupled, 
partial reactions. A classic example is the coupling of ATP 
synthesis to electron transport resulting in oxidative phos- 
phorylation by mitochondrial membranes (Racker,  1976). 
When a key component (the F1 ATPase)  is removed (or if 
certain uncoupling drugs are added), ATP synthesis stops 
but respiration continues, now uncoupled from phosphoryla- 
tion.  Monitoring the wrong partial reaction (e.g.,  oxygen 
consumption) would lead to the erroneous conclusion that F1 
is unimportant. (Our experience is also a nice illustration of 
Rackers "TAGFY" view, discussed in lecture 1 in his book 
[Racker,  1976]). 
In the case of  reconstituted transport, exclusively monitor- 
ing processing of the cargo protein can now be expected to 
lead  to  false  negatives  regarding  the  requirements  for 
coatomer and ARF because this signal will persist in an 
uncoupled fusion reaction. In light of our new findings, in 
retrospect  it would have been wiser  to  have defined the 
GTPTS-sensitive  component  (Melan~on  et  al.,  1987)  of 
VSV-G protein processing to be the authentic signal in the 
cell-free system.  As  a  result,  cytosol fractions providing 
ARE coatomer, and RF would have been retained during the 
systematic fractionation  to yield the minimum set of  required 
components and no doubt these  components would have 
been discovered in this context. Our original finding that in- 
hibition by GTPTS was most pronounced as cytosol concen- 
tration is increased (Melan~on et al., 1987) can now be un- 
derstood to mean that fusion becomes uncoupled as cytosol 
concentration is lowered because coat proteins are limiting 
in crude cytosol. Because the cytosol and Golgi concentra- 
tions used in cell-free assays are "o200-fold lower and 10-fold 
lower than in a cell, respectively, the ratio of  cytosol to Golgi 
is ,v20-fold lower in vitro than in cells. Thus, increasing the 
concentration of cytosol in the cell-free system is in the phys- 
iological direction; lowering the concentration is nonphysio- 
logical.  The  report  that  reducing  ARF  concentration in 
cytosol does not affect the Golgi assay signal (Taylor et al., 
1992) is now easily explained, and the inhibition of in vitro 
nuclear envelope fusion by mARF1 can now be rationalized 
by assembly of coats on these membranes (Boman et al., 
1992). 
NSF (Block et al.,  1988;  Malhotra et al.,  1989),  SNAP 
(Clary et al., 1990),  and pl15 (Waters et al., 1992b) are all 
required for vesicular transport in crude cytosol and for un- 
coupled transport. Because uncoupled fusion uses the same 
cytosolic fusion machinery as coupled (vesicle)  fusion, the 
simplest possibility is that in the case of uncoupled fusion 
the donor and acceptor membranes now pair directly, with- 
out involving an intervening vesicle. In terms of the SNARE 
hypothesis (S611ner et al., 1993) for vesicle targeting, this di- 
rect pairing model would mean that the same v-SNARE that 
would normally first be packaged into a transport vesicle and 
only then be able to interact with a t-SNARE in the target 
membrane would now interact while still in the donor mem- 
brane. We envision that as soon as a free v-SNARE or other 
donor membrane-derived fusion protein appears in a donor 
membrane, it rapidly assembles itself into coated buds, and 
is thereby sequestered and prevented from productively en- 
gaging t-SNAREs until the coat is removed when ARF's 
bound GTP is hydrolyzed (Tanigawa et al., 1993) after bud- 
ding is finished, thereby assuring that fusion follows bud- 
ding.  When coat assembly is prevented,  free v-SNAREs 
would accumulate at the donor membrane, with nothing to 
prevent them from pairing directly with t-SNAREs at the tar- 
get  membrane and then using the  general cytosolic ma- 
chinery to trigger fusion. In the absence of RF, and the pres- 
ence of excess coat proteins, coated vesicles containing the 
full supply of v-SNAREs would accumulate, preventing un- 
coupled fusion, but the accumulated coated vesicles could 
not be consumed. When these coats cannot be removed (as 
when GTP3,S, or the ARF GTPase mutant is used), even RF 
cannot enable these vesicles to engage in fusion. This mech- 
anism can easily explain why in earlier work (Orci et al., 
1991) preincubation of Golgi membranes with GTP'tS and 
cytosol prevented the BFA-induced fusion of Golgi mem- 
branes.  To  be  efficiently packaged  into  coated  vesicles, 
v-SNAREs (and other membrane proteins) need only bind 
to ARF or to the postulated (Helms et al.,  1993) ARF re- 
ceptor. 
With our new results, a straightforward explanation of the 
two principal effects of BFA on whole cells (Klausner et al., 
1992) and the cell-free system (Orci et al.,  1991) seems at 
hand. These are a block in protein secretion, and fusion of 
Golgi cisternae to  each  other  and to  the  ER,  a  process 
termed "retrograde transport" (Lippincott et al., 1989). The 
block to secretion is explained by the block of COP-coated 
vesicle assembly secondary to the inhibition of nucleotide 
exchange of ARF  (Donaldson et al.,  1992b;  Helms  and 
Rothman, 1992).  We now propose that the phenomenon of 
"retrograde transport" is due to uncoupled fusion between 
successive pairs of donor and acceptor compartments along 
the secretory pathway that are normally connected by COP- 
coated transport vesicle shuttles (involving only those compart- 
ments housing BFA-sensitive ARF nucleotide exchange fac- 
tors). In terms of the SNARE hypothesis, perhaps v-SNAREs 
in the ER would now pair directly with t-SNAREs in the cis- 
Golgi, those in cis with those in medial, etc., until all of  these 
compartments have collapsed into the ER. Specificity must 
be inherent in this massive fusion event, for while ER and 
Golgi membranes are engaged, nearby late endosomes and 
TGN are typically not involved (Chege and Pfeffer,  1990; 
Hunziker et al., 1991; Lippincott et al., 1991; Wood et al., 
1991). Because the ER is further away from Golgi cisternae 
than the cisternae are from each other, fusion of ER with cis 
Golgi should be the slowest step, and hence the one most eas- 
ily visualized by microscopy (Lippincott et al., 1990).  Por- 
tions of the Golgi membrane can take the shape of tubules 
before this  fusion reaction,  perhaps  because microtubule 
motor binding sites normally sequestered in coats are ex- 
posed (Pelham, 1991b), However, neither microtubules nor 
the membrane tubules are necessary for the ER-Golgi fusion 
process, as disassembling microtubules abolishes membrane 
tubules and slows the rate but does not affect the extent of 
ER-Golgi fusion (Lippincott et al.,  1990). 
An additional kind of retrograde transport from Golgi to 
ER surely exists to recycle key membrane proteins, and has 
been directly demonstrated in the case of KDEL receptors 
that retrieve escaped ER resident proteins (Pelham, 1991a) 
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It seems doubtful that any low level of uncoupled fusion that 
might occur physiologically (without BFA) could be relevant 
to selective retrograde  movements like KDEL and KKXX- 
dependent retrieval,  which are by definition signal-depen- 
dent; direct fusion of ER and proximal Golgi would have to 
be unselective, returning an entire cisterna at a time. How- 
ever, it cannot be excluded that uncoupled fusion could con- 
tribute a basal mechanism for recycling Golgi membrane for 
re-sorting or repair, and this process could well explain the 
occasional continuities among ER and Golgi cisternal mem- 
branes that have been noted (Cooper et al., 1990; Rambourg 
and Clermont, 1990). The remarkable fact that the intermix- 
ing of ER and Golgi triggered by BFA is fully reversible (Lip- 
pincott et al., 1989) reveals that low levels of uncoupled fu- 
sion can no doubt be tolerated by cells even if this process 
is not gainfully  employed,  allowing a relatively  imprecise 
coupling mechanism to suffice. 
The cytosol requirement for vesicular transport seems to 
be  fulfilled by  a  relatively  small  number  of components. 
Coatomer and N-myristylated ARF are required for vesicle 
budding, RF is needed in a process following budding (per- 
haps to help trigger uncoating, since locking coats in place 
with GTP3,S  or the ARF mutant  prevents  RF action) and 
only NSF,  SNAP, pl15,  Ia,  and 113 are required  for mem- 
brane fusion. With the recent discovery of the SNAP recep- 
tors in both vesicle and target  membranes  (Sollner et al., 
1993),  a clear outline of the machinery and mechanisms of 
intracellular  transport  is beginning to emerge. 
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